Pressure BioSciences, Inc. (PBIO)

Market Cap	21.48K -99.5%
Revenue (ttm)	1.50M -25.3%
Net Income	-33.25M
EPS	-0.89
Shares Out	42.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	9,163
Open	0.0005
Previous Close	0.0005
Day's Range	0.0005 - 0.0005
52-Week Range	0.0001 - 0.2000
Beta	-0.09
RSI	47.46
Earnings Date	Mar 27, 2026

About Pressure BioSciences

Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company’s products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formulations; BaroFold Technology platform, that is used to improve the quality and lower the production costs of protein biotherapeutics; and Pressure Cycli...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1978
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: PBIO

Financial Performance

In 2023, Pressure BioSciences's revenue was $1.98 million, an increase of 14.36% compared to the previous year's $1.73 million. Losses were -$35.20 million, 97.7% more than in 2022.